Study on sepsis types and antibiotics for severe pneumonia
Part of Infections, Lungs & breathing clinical trials.
This study looks at different types of sepsis in patients with severe pneumonia. It aims to see how the type of sepsis affects treatment with a common antibiotic called piperacillin/tazobactam.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are in the intensive care unit (ICU) and need support for at least one organ (like a breathing machine or medicines for blood pressure).
- You have a serious lung infection (pneumonia) that is confirmed or strongly suspected.
- You are getting or about to get a specific antibiotic called piperacillin/tazobactam (also known as Zosyn, Tazocin, or Pip-Taz).
- You or your family must agree to be in the study, or the hospital can use a special process to include you quickly if you cannot consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two common antibiotics, meropenem and piperacillin/tazobactam, to see which works better for adults with sepsis who are critically ill. It aims to help doctors choose the best treatment for serious infections.
This study compares two antibiotics—piperacillin-tazobactam or temocillin—to treat severe ICU infections caused by certain hard-to-treat gut bacteria (ESBL). It may help patients avoid the use of carbapenem antibiotics like meropenem when the bacteria are susceptible.
This trial studies treatments for sepsis, a serious infection complication, in ICU patients. It aims to find better ways to care for critically ill patients with sepsis.
This study watches how safely two common antibiotics (vancomycin and a combination called piperacillin/tazobactam) work together in hospitalized patients with serious infections. Researchers want to make sure the combination doesn't harm kidney function.
This trial tests whether giving a certain type of antibiotic (beta-lactam) continuously or intermittently works better for patients in the intensive care unit with pneumonia or a urinary tract infection and signs of sepsis. Sepsis is a serious response to an infection, so better antibiotic delivery could improve outcomes.
This is a retrospective study (looking back at past patient records) of people hospitalized with pneumonia to understand how the disease progresses and what factors affect recovery. Researchers will examine medical records of pneumonia patients admitted within 72 hours of symptom onset to identify patterns in who recovers well and who develops serious complications.
Hear when a new Respiration Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.